Skip to content

Dr. Patrick Braeckman

Active
Private limited companyfounded 2005active for 21 yearsTasscheweg 13, 8800 Roeselare, BelgiumKBO/BCE: BE 0874.988.203
Summary

Dr. Patrick Braeckman has been active since 2005 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €12,400 and a net result of €156,627. Equity has been shrinking by about 6.3% per year since 2019. Its solvency ranks better than 11% of 20,700 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 11-07-2005 Normal situation
Activity
Specialist medical practice NACE 86220
Establishment unit
2.302.442.082 9600 Ronse, since 11-07-2005
Financial year end
30 June
Peppol
Reachable since 11-03-2026

Board and ownership

Board

Financial position

92 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts to 30-06-2025
Gross margin
€220,890
▲ 18.1%
Turnover
≈ €410,000
estimated
Profit
€156,627
▲ 17.8%
Equity
€12,400
▼ 34.9%
Total assets
€202,650
▲ 2.3%
  • 2025 accounts filed 2 days after the deadline
Filed on 02-02-2026
Score breakdownraises riskEquity €12,400 (6.1% of total assets)lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 1.00, cash €148,915Size: total assets €202,650Show the evidence

Checked score

Score 2025
92 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 34% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 31-4
equity 6.1% of total assets
Liquidity 53-7
short-term debt 84.6% · cash 73.5%
Profitability 100=
return on assets 77.3%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: 0.1%▲ +0.1 percentage points vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025highest value 03-2025: < 0.1%▼ -0.1 percentage points vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025lowest value 08-2025: < 0.1%● unchanged vs 07-2025lowest value 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €1,000 on 30-day terms is acceptable
Liquidity is insufficient, with a current ratio of 1.0 (1.07 in 2024), below 1. Short-term debt is 84.6% and cash 73.5% of total assets. 93.9% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 11% of them on solvency, 28% on liquidity, 80% on profitability and 16% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 1.00, cash €148,915
NBB · annual accounts
raises risk · Equity €12,400 (6.1% of total assets)
NBB · annual accounts
lowers risk · Size: total assets €202,650
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 11% of 20700 sector peers (2025).
NBB · sector comparison
Position among 20700 sector peers
Solvency
better than 11%
← weakest strongest →
neutral · A punctual record breaks
This company filed 9 consecutive financial years on time. The year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 02-02-2026, 2 days late. Weigh it accordingly: of the companies that move to filing 1 to 90 days late, 1.41% are now bankrupt, dissolved or in another special legal status, below the 1.66% of all filers. It is a change in behaviour, not evidence of elevated risk.
NBB · 10 filings
Deviation from the deadline
2025
2 days late
2024
on the day
2023
on the day
2022
on the day
2021
on the day
2020
3 days early
2019
9 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 1 day before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-06-2026 is due by 31-01-2027. Nothing is late today. The company usually files around 31 January (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
30-06-2026 year end02-11-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Caution: Lower solvency than 88% of companies in human healthsector median 63.0% · 20,700 companies 6.1% View
  • Positive: 7 profitable years in a rowprofit 2025: €156,627 7 years View

Recent changes

  1. · Gazette deed Change of role: Patrick Braeckman, from manager to director
  2. · Gazette deed Incorporation
All 13 events

Comparable companies

These companies have the same main activity as Dr. Patrick Braeckman: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €175,000 and €271,000, founded between 1998 and 2008.

CompanyTotal assetsGross margin
Dr. Patrick Braeckman Roeselare€202,650€220,890
DR. VERMEERSCH KAREN Genk€213,486€182,427
Dr. Dirk Vervloessem Duffel€255,065€190,097
Dokter Philip Loquet Aartselaar€176,283€201,641
Dr BETEK Ans€264,045€196,361
DR VERSCHUEREN PAIN CONSULT Ath€270,751€236,775
DOCTEUR HENKES Le Roeulx€174,684€198,939
Full comparison

Key facts about Dr. Patrick Braeckman

What is the company number of Dr. Patrick Braeckman?
The company number of Dr. Patrick Braeckman is 0874.988.203. The VAT number is the same number with BE in front: BE 0874.988.203.
Where is Dr. Patrick Braeckman based?
The registered office is at Tasscheweg 13, 8800 Roeselare.Company details
What does Dr. Patrick Braeckman do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. Patrick Braeckman?
The legal form of Dr. Patrick Braeckman is Private limited company (BV).
When was Dr. Patrick Braeckman founded?
Dr. Patrick Braeckman was founded on 11-07-2005.
Is Dr. Patrick Braeckman still active?
Yes, Dr. Patrick Braeckman is an active enterprise in the KBO register.
What is the turnover of Dr. Patrick Braeckman?
The turnover in financial year 2025 is ≈ €410,000. This figure is estimated from the gross margin of €220,890 and 43 comparable companies (NACE 86220). It probably lies between €350,000 and €550,000.Financials
Is Dr. Patrick Braeckman profitable?
In financial year 2025, Dr. Patrick Braeckman made a profit of €156,627.
Where can I find the annual accounts of Dr. Patrick Braeckman?
Dr. Patrick Braeckman filed 20 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Patrick Braeckman due?
Dr. Patrick Braeckman must file the annual accounts for financial year 2026 by 31-01-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.